Findings

What do systematic reviews say?

6 questions · 6 findings · 1 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 16.7%Low 5 · 83.3%Moderate 0 · 0%High 0 · 0%

Low molecular weight heparin vs control

CVC‐related thrombosis ( · children with a CVC

Does low molecular weight heparin prevent central venous… showed no clear difference in CVC‐related thrombosis ( compared with control (low certainty).

1 finding from 1 review

Low molecular weight heparin for prevention of central venous catheter‐related thrombosis in children 2020 · Cochrane Headline outcomes only
RR 0.68 [0.27, 1.75]
2 studies · 787 participants
Low

Low molecular weight heparin vs control

Symptomatic catheter‐related thrombosis (up to 3 months) · children with a CVC

Does low molecular weight heparin prevent central venous… showed no clear difference in symptomatic CVC‐related thrombosis ( compared with control (low certainty).

1 finding from 1 review

Low molecular weight heparin for prevention of central venous catheter‐related thrombosis in children 2020 · Cochrane Headline outcomes only
RR 1.03 [0.21, 4.93]
1 study · 158 participants
Low

Low molecular weight heparin vs control

Asymptomatic CVC‐related thrombosis ( · children with a CVC

Does low molecular weight heparin prevent central venous… showed no clear difference in asymptomatic CVC‐related thrombosis ( compared with control (low certainty).

1 finding from 1 review

Low molecular weight heparin for prevention of central venous catheter‐related thrombosis in children 2020 · Cochrane Headline outcomes only
RR 1.17 [0.45, 3.08]
1 study · 158 participants
Low

Low molecular weight heparin vs control

Major bleeding · children with a CVC

Does low molecular weight heparin prevent central venous… showed no clear difference in major bleeding ( compared with control (low certainty).

1 finding from 1 review

Low molecular weight heparin for prevention of central venous catheter‐related thrombosis in children 2020 · Cochrane Headline outcomes only
RR 0.27 [0.05, 1.67]
2 studies · 813 participants
Low

Low molecular weight heparin vs control

Minor bleeding · children with a CVC

1 finding from 1 review

Low molecular weight heparin for prevention of central venous catheter‐related thrombosis in children 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 813 participants
Very low

Low molecular weight heparin vs control

Death during study period · children with a CVC

1 finding from 1 review

Low molecular weight heparin for prevention of central venous catheter‐related thrombosis in children 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 813 participants
Low